Antonia, S. J., Gettinger, S., Chow, L. Q., Juergens, R., Borghaei, H., Shen, Y., … Rizvi, N. A. (2014). NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE NON-SMALL-CELL LUNG CARCINOMA (NSCLC): INTERIM PHASE I RESULTS. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 10, pp. 155–155). WILEY-BLACKWELL.

Antonia, Scott J., Scott Gettinger, Laura Q. Chow, Rosalyn Juergens, Hossein Borghaei, Yun Shen, Christopher Harbison, Allen C. Chen, Neal E. Ready, and Naiyer A. Rizvi. “NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE NON-SMALL-CELL LUNG CARCINOMA (NSCLC): INTERIM PHASE I RESULTS.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10:155–155. WILEY-BLACKWELL, 2014.

Antonia SJ, Gettinger S, Chow LQ, Juergens R, Borghaei H, Shen Y, et al. NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE NON-SMALL-CELL LUNG CARCINOMA (NSCLC): INTERIM PHASE I RESULTS. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL; 2014. p. 155–155.

Antonia, Scott J., et al. “NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE NON-SMALL-CELL LUNG CARCINOMA (NSCLC): INTERIM PHASE I RESULTS.” ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 10, WILEY-BLACKWELL, 2014, pp. 155–155.

Antonia SJ, Gettinger S, Chow LQ, Juergens R, Borghaei H, Shen Y, Harbison C, Chen AC, Ready NE, Rizvi NA. NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE NON-SMALL-CELL LUNG CARCINOMA (NSCLC): INTERIM PHASE I RESULTS. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL; 2014. p. 155–155.